FI89004C - Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat - Google Patents
Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparatInfo
- Publication number
- FI89004C FI89004C FI880712A FI880712A FI89004C FI 89004 C FI89004 C FI 89004C FI 880712 A FI880712 A FI 880712A FI 880712 A FI880712 A FI 880712A FI 89004 C FI89004 C FI 89004C
- Authority
- FI
- Finland
- Prior art keywords
- acid derivative
- compound
- absorption rate
- regulating
- laekemedelspreparat
- Prior art date
Links
- 238000010521 absorption reaction Methods 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 230000001105 regulatory effect Effects 0.000 abstract 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical class C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 abstract 1
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 abstract 1
- 235000012254 magnesium hydroxide Nutrition 0.000 abstract 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 abstract 1
- 239000000347 magnesium hydroxide Substances 0.000 abstract 1
- 235000012245 magnesium oxide Nutrition 0.000 abstract 1
- 239000000395 magnesium oxide Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000005599 propionic acid derivatives Chemical class 0.000 abstract 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Exhaust-Gas Circulating Devices (AREA)
- Automatic Tape Cassette Changers (AREA)
- Small-Scale Networks (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI880712A FI89004C (fi) | 1988-02-16 | 1988-02-16 | Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat |
| EP89902387A EP0414688B1 (en) | 1988-02-16 | 1989-02-15 | Process for regulating the absorption rate of drugs and a pharmaceutical formulation |
| AU30623/89A AU3062389A (en) | 1988-02-16 | 1989-02-15 | Process for regulating the absorption rate of drugs and a pharmaceutical formulation |
| AT89902387T ATE110266T1 (de) | 1988-02-16 | 1989-02-15 | Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung. |
| DE68917727T DE68917727T2 (de) | 1988-02-16 | 1989-02-15 | Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung. |
| PCT/FI1989/000024 WO1989007439A1 (en) | 1988-02-16 | 1989-02-15 | Process for regulating the absorption rate of drugs and a pharmaceutical formulation |
| FI906237A FI89240C (fi) | 1988-02-16 | 1990-12-18 | Anvaendning av tillsatsmedel foer oekning av ibuprofens absorptionshastighet |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI880712A FI89004C (fi) | 1988-02-16 | 1988-02-16 | Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat |
| FI880712 | 1988-02-16 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI880712A0 FI880712A0 (fi) | 1988-02-16 |
| FI880712L FI880712L (fi) | 1989-08-17 |
| FI89004B FI89004B (fi) | 1993-04-30 |
| FI89004C true FI89004C (fi) | 1993-08-10 |
Family
ID=8525923
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI880712A FI89004C (fi) | 1988-02-16 | 1988-02-16 | Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat |
| FI906237A FI89240C (fi) | 1988-02-16 | 1990-12-18 | Anvaendning av tillsatsmedel foer oekning av ibuprofens absorptionshastighet |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI906237A FI89240C (fi) | 1988-02-16 | 1990-12-18 | Anvaendning av tillsatsmedel foer oekning av ibuprofens absorptionshastighet |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0414688B1 (fi) |
| AT (1) | ATE110266T1 (fi) |
| AU (1) | AU3062389A (fi) |
| DE (1) | DE68917727T2 (fi) |
| FI (2) | FI89004C (fi) |
| WO (1) | WO1989007439A1 (fi) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533162A1 (de) * | 1995-09-08 | 1997-03-13 | Bayer Ag | Pharmazeutisches Kombinationspräparat mit Ketoprofen |
| TW430561B (en) * | 1995-12-20 | 2001-04-21 | Gea Farmaceutisk Fabrik As | Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet |
| EP1800667A1 (en) | 2005-12-23 | 2007-06-27 | Losan Pharma GmbH | Rapidly solubilizing ibuprofen granulate |
| EP1863460B1 (en) | 2005-03-22 | 2013-01-16 | Losan Pharma GmbH | Solubilized ibuprofen |
| US11135188B2 (en) | 2009-05-11 | 2021-10-05 | Bayer Healthcare Llc | Method and composition to improve absorption of therapeutic agents |
| JP2014098009A (ja) * | 2014-01-29 | 2014-05-29 | Ss Pharmaceut Co Ltd | 経口用イブプロフェン製剤 |
| CA3201462A1 (en) | 2020-11-13 | 2022-05-19 | Bayer Healthcare Llc | Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217340A (en) * | 1979-03-21 | 1980-08-12 | Merck & Co., Inc. | Rapid acting combination of phenyl benzoic acid compounds and magnesium hydroxide |
| US4294819A (en) * | 1980-08-18 | 1981-10-13 | Bristol-Myers Company | Alkaline analgesic capsule |
| DE3151196A1 (de) * | 1981-12-23 | 1983-06-30 | Kurt Heinz Prof. Dr. 7800 Freiburg Bauer | Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen |
| CA1234761A (en) * | 1984-08-10 | 1988-04-05 | Herbert Lapidus | Chewable aspirin and buffering material tablet and method for producing same |
-
1988
- 1988-02-16 FI FI880712A patent/FI89004C/fi not_active IP Right Cessation
-
1989
- 1989-02-15 AU AU30623/89A patent/AU3062389A/en not_active Abandoned
- 1989-02-15 EP EP89902387A patent/EP0414688B1/en not_active Expired - Lifetime
- 1989-02-15 AT AT89902387T patent/ATE110266T1/de not_active IP Right Cessation
- 1989-02-15 WO PCT/FI1989/000024 patent/WO1989007439A1/en not_active Ceased
- 1989-02-15 DE DE68917727T patent/DE68917727T2/de not_active Expired - Fee Related
-
1990
- 1990-12-18 FI FI906237A patent/FI89240C/fi active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| FI880712L (fi) | 1989-08-17 |
| FI89240C (fi) | 1993-09-10 |
| FI880712A0 (fi) | 1988-02-16 |
| ATE110266T1 (de) | 1994-09-15 |
| FI906237A0 (fi) | 1990-12-18 |
| EP0414688B1 (en) | 1994-08-24 |
| EP0414688A1 (en) | 1991-03-06 |
| DE68917727D1 (de) | 1994-09-29 |
| FI89240B (fi) | 1993-05-31 |
| DE68917727T2 (de) | 1995-04-06 |
| WO1989007439A1 (en) | 1989-08-24 |
| AU3062389A (en) | 1989-09-06 |
| FI89004B (fi) | 1993-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0037943B1 (en) | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom | |
| HK57184A (en) | Diphenylbutyl-piperazinecarboxamides | |
| AU6767587A (en) | Pharmaceutical compositions | |
| WO2002064148A3 (en) | Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders | |
| AU2915789A (en) | Pharmaceutical compositions | |
| EP0461630A3 (en) | Production process of microspheres | |
| EG17609A (en) | Process for preparation of therapeutic agents from derivatives of propoimic acid. | |
| AU629977B2 (en) | 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors | |
| AU8268591A (en) | Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions | |
| FI89004C (fi) | Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat | |
| IL90056A0 (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
| SG59982A1 (en) | Solution of sparfloxacin its preparation and salt of which it is composed | |
| HUT49614A (en) | Process for producing cefalosporin derivatives and pharmaceutical compositions comprising these compounds | |
| AU3929789A (en) | New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates | |
| KR940018351A (ko) | 노나테트라에노산 유도체 | |
| Pitkin et al. | Serum protein binding alterations of selected cephalosporin antibiotics by fatty acids and their derivatives | |
| IE822853L (en) | 1-piperazino carboxylates | |
| IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
| ES2104193T3 (es) | Procedimiento para la preparacion de acidos 4,5-difluoro-benzoicos, derivados de acidos 4,5-difluoro-benzoicos y 4,5-difluoro-benzaldehidos. | |
| JPS57106644A (en) | Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation | |
| ZA828237B (en) | A vasodilator compound,process for the preparation thereof and pharmaceutical compositions therefrom | |
| JPS56158788A (en) | Cephalosporin compound for oral use | |
| JPS57203035A (en) | Carboxylic acid ester | |
| JPS57136586A (en) | Cephalosporin derivative and its preparation | |
| EP0389773A3 (de) | Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: NEUVONEN, PERTTI J. |